共 50 条
The CRAFITY score: A promising prognostic predictor for patients with hepatocellular carcinoma treated with tyrosine kinase inhibitor and immunotherapy combinations
被引:23
|作者:
Yang, Yi
[1
,2
,3
]
Ouyang, Jingzhong
[4
]
Zhou, Yanzhao
[4
]
Zhou, Jinxue
[4
]
Zhao, Hong
[1
,2
,3
]
机构:
[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Hepatobiliary Surg, Natl Canc Ctr, Canc Hosp,Natl Clin Res Ctr Canc, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Key Lab Gene Editing Screening & Res, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Dev R&D Digest Syst Tumor Drugs, Beijing, Peoples R China
[4] Zhengzhou Univ, Dept Hepatobiliary & Pancreat Surg, Affiliated Canc Hosp, Zhengzhou, Henan, Peoples R China
基金:
中国国家自然科学基金;
关键词:
D O I:
10.1016/j.jhep.2022.03.018
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
引用
收藏
页码:574 / 576
页数:3
相关论文